Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Allograft”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05672550
What this trial is testing

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)

Who this might be right for
Pediatric Kidney Transplant Recipients
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT03591380
What this trial is testing

CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Wisconsin, Madison 3
Not applicableStudy completedNCT00695097
What this trial is testing

The Effect of Rituximab on the Development of Anti-Donor Antibodies

Who this might be right for
Renal Transplant Rejection
University of California, San Francisco 18
Testing effectiveness (Phase 2)Study completedNCT00365846
What this trial is testing

"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

Who this might be right for
Renal Transplant
University of Wisconsin, Madison 29
Not applicableStudy completedNCT00658073
What this trial is testing

Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts

Who this might be right for
Renal Transplant Rejection
Fuzhou General Hospital 165
Testing effectiveness (Phase 2)Looking for participantsNCT07641426
What this trial is testing

A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection (ABMR).

Who this might be right for
Antibody Mediated Rejection
CASI pharmaceuticals, Inc. 58
Large-scale testing (Phase 3)Not Yet RecruitingNCT06582485
What this trial is testing

A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys

Who this might be right for
Ischemia-reperfusion InjuryKidney Transplant; Complications
iCoat Medical AB 200
Large-scale testing (Phase 3)Study completedNCT00000935
What this trial is testing

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT00275522
What this trial is testing

The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

Who this might be right for
Kidney Transplant
Mayo Clinic 16
Post-approval studies (Phase 4)Study completedNCT00129961
What this trial is testing

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Who this might be right for
Skin NeoplasmsKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 86
Large-scale testing (Phase 3)Not Yet RecruitingNCT07835581
What this trial is testing

Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 620
Testing effectiveness (Phase 2)WithdrawnNCT00556257
What this trial is testing

Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer
Not applicableStudy completedNCT00270712
What this trial is testing

Factors That Affect Long-Term Kidney Transplant Function

Who this might be right for
Kidney Transplant
University of Minnesota 3,175
Not applicableStudy completedNCT00697112
What this trial is testing

Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

Who this might be right for
Renal Transplantation
Pfizer 53
Not applicableStudy completedNCT03723668
What this trial is testing

Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France

Who this might be right for
Kidney FailureTransplant;Failure,Kidney
Paris Translational Research Center for Organ Transplantation 94,017
Testing effectiveness (Phase 2)Study completedNCT00257387
What this trial is testing

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 120
Post-approval studies (Phase 4)Study completedNCT00866879
What this trial is testing

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

Who this might be right for
Renal Transplant Rejection
Northwestern University 275
Not applicableStudy completedNCT01346397
What this trial is testing

Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

Who this might be right for
Acute Graft RejectionChronic Allograft NephropathyPolyomavirus-related Transplant Nephropathy
Russian Academy of Medical Sciences 170
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Not applicableStudy completedNCT03155763
What this trial is testing

Histology of Implantation Biopsies and Kidney Allograft Outcomes

Who this might be right for
Kidney Graft Dysfunction
Andriy Trailin 130
Next Page